2024-03-26T21:22:02-05:00 2023-06-30 113066459 CERINI & ASSOCIATES LLP 3340 VETERANS MEMORIAL HWY BOHEMIA NY 11716 990 2022-07-01 943342838 ANIMAL CANCER FOUNDATION ANIM 5168584960 1051 PORT WASHINGTON BLVD BOX 1548 PORT WASHINGTON NY 11050 BARBARA COHEN EXECUTIVE DIRECTOR 5168584960 2024-03-26 1 BARBARA COHEN 999009999 0 TANIA QUIGLEY P01549343 6315821600 2024-03-26 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z BARBARA COHEN 1051 PORT WASHINGTON BLVD BOX 1548 PORT WASHINGTON NY 11050 521484 0 X WWW.ACFOUNDATION.ORG X 1999 CA SEE SCHEDULE O.ACF DEVELOPS AND SUPPORTS RESEARCH THAT ADVANCES THE PREVENTION AND TREATMENT OF CANCER FOR PEOPLE AND PETS. ACF FOCUSES ON FURTHERING RESEARCH IN COMPARATIVE ONCOLOGY, WHICH IS THE STUDY OF CANCERS THAT OCCUR SIMILARLY IN BOTH COMPANION ANIMALS AND HUMANS.TO FUND AND DEVELOP RESEARCH FOCUSED ON THE BIOLOGIC SIMILARITY OF CANCER IN PETS AND PEOPLE THAT WILL EXPEDITE THERAPEUTIC AND PREVENTATIVE BENEFITS FOR BOTH. ALSO, TO INFORM THE PUBLIC AND THE SCIENTIFIC COMMUNITY ABOUT THE BIOLOGIC SIMILARITY OF CANCER IN PETS AND PEOPLE, AND TO COMMUNICATE THE WAYS IN WHICH COMPARATIVE ONCOLOGY WILL ACCELERATE THE TREATMENT, PREVENTION AND ULTIMATE ERADICATION OF CANCER. THE CANINE CANCER GENOME PROJECT (CCGP) SPONSORED BY BLUE BUFFALO FOUNDATION AND ANIMAL CANCER FOUNDATION SEEKS TO MAP THE SEVEN MOST COMMON CANINE CANCER TUMORS AND TO PLACE THE DATASETS IN THE PUBLIC DOMAIN FOR USE BY ALL CANCER RESEARCHERS. 6 6 3 0 0 0 256604 494631 0 0 17224 8333 382 16899 274210 519863 0 0 0 0 173341 203688 0 0 156527 128985 199291 302326 402979 -28116 116884 777780 930046 9205 26474 768575 903572 X ANIMAL CANCER FOUNDATION IS DEDICATED TO FINDING NEW TREATMENTS AND EVENTUAL CURES FOR CANCER BY FUNDING RESEARCH IN AND INCREASING PUBLIC AWARENESS OF COMPARATIVE ONCOLOGY, THE STUDY OF NATURALLY OCCURRING, SIMILAR CANCERS IN PEOPLE AND IN COMPANION ANIMALS. 0 0 165419 ANIMAL CANCER FOUNDATION HAS EMBARKED ON THE CANINE CANCER GENOME PROJECT ("CCGP") SPONSORED BY BLUE BUFFALO FOUNDATION TO ENABLE A MULTI-INSTITUTIONAL SCIENTIFIC INVESTIGATIONAL COLLABORATION TO MAP CANINE CANCER GENOMES FROM SAMPLES DONATED TO ACF BY THE CANINE CANCER ONCOLOGY GENOMICS CONSORTIUM (CCOGC) AND TO PLACE THOSE DATASETS IN THE PUBLIC DOMAIN FOR USE BY ALL CANCER RESEARCH. THIS MULTI-YEAR PROJECT WILL ENABLE CANCER SCIENTISTS TO BUILD MORE ROBUST COMPARATIVE DATASETS AND TO FURTHER CANCER RESEARCH IN PETS AND PEOPLE. AFTER A COMPETITIVE SELECTION PROCESS, THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE WAS SELECTED AS THE PRINCIPAL INVESTIGATORS FOR THIS PROJECT.ACF COMPARATIVE ONCOLOGY GRANTS AWARDS ARE RESEARCH GRANTS OF $50,000 FOR ONE TO TWO YEAR COMPARATIVE ONCOLOGY RESEARCH THAT IS IDENTIFIED BY A SCIENTIFIC ADVISORY COUNCIL AS BEST-IN-FIELD EARLY DEVELOPMENT THAT WILL HAVE RESULTS POISED TO ATTRACT FURTHER GOVERNMENT AND LARGE INSTITUTIONAL FUNDING AND THAT ENCOURAGE OPEN SHARE DISCOVERY TO SPEED NEW SCIENTIFIC INFORMATION AND TREATMENT TO THE CLINICAL SETTING. THESE RFPS ARE OPENED AT THE DISCRETION OF THE ACF BOARD OF DIRECTORS.ACF SUPPORTS WORKSHOPS, SYMPOSIA AND CONFERENCES FURTHERING COMPARATIVE ONCOLOGY THAT INCLUDE THE VETERINARY CANCER SOCIETY ("VCS") ANNUAL CONFERENCE. 165419 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 10 0 1 3 1 0 0 0 0 0 0 0 0 0 0 0 0 X 6 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 0 1 0 0 NY CA X X X THE ORGANIZATION 5168584960 1051 PORT WASHINGTON BLVD BOX 1548 PORT WASHINGTON NY 11050 LONI EDWARDS DIRECTOR 3.00 X 0 0 0 GERALD POST PRESIDENT 3.00 X X 0 0 0 MATTHEW VUOLO GOVERNANCE/NOMINATING COMMITTEE CHAIR 3.00 X 0 0 0 RENEE ALSARRAF SECRETARY 3.00 X X 0 0 0 VICTORIA CARMELLA DIRECTOR 3.00 X 0 0 0 KAREN LABARRE DIRECTOR 3.00 X 0 0 0 BARBARA COHEN EXECUTIVE DIRECTOR 40.00 X 74000 0 0 74000 0 0 0 0 0 0 0 494631 494631 7662 7662 2292 1621 671 671 671 SPONSORSHIP 900099 16000 16000 MISCELLANEOUS 900099 899 899 16899 519863 17570 0 7662 X 74000 51800 7400 14800 114754 40786 11476 62492 493 192 49 252 14441 7082 1446 5913 115764 49333 45998 20433 370 370 6175 29 188 5958 16625 10687 570 5368 1351 470 881 6040 5864 176 SPONSORSHIPS 16500 16500 PRINTING AND POSTAGE 13852 996 810 12046 MARKETING 11779 2903 8876 MISCELLANEOUS 3768 217 1404 2147 7067 924 4577 1566 402979 165419 81033 156527 193229 174601 319591 343008 698 128557 292 6228 17233 27128 27128 0 0 258034 266355 777780 930046 9205 26474 9205 26474 X 238296 382932 530279 520640 768575 903572 777780 930046 116884 20935 -2822 0 X 0 1 X 1 0 X 837412 367712 310790 256604 494631 2267149 837412 367712 310790 256604 494631 2267149 2267149 9011 18391 6031 4782 7662 45877 175 382 16899 17456 2330482 0.97280 0.97940 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1628 1628 0 25500 25500 0 0 X 627810 20935 89834 110769 517041 2822 2822 519863 492813 89834 89834 402979 0 402979 PART X, LINE 2: ACF IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS PUBLICLY SUPPORTED AS DESCRIBED IN SECTION 509(A). ACF EVALUATED ITS TAX FILINGS FOR UNCERTAIN TAX POSITIONS AND HAS DETERMINED THAT THERE WERE NO UNCERTAIN TAX POSITIONS FOR FISCAL YEARS 2023 AND 2022. FORM 990, PART VI, SECTION B, LINE 11B THE 990 DRAFT IS PROVIDED TO EACH BOARD MEMBER FOR COMPLETE REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE FOUNDATION MONITORS THEIR CONFLICT OF INTEREST POLICY AT THEIR BOARD MEETINGS. THE POLICY IS ENFORCED ON AN ONGOING BASIS. FORM 990, PART VI, SECTION B, LINE 15A THE FOUNDATION HAS THREE EMPLOYEES WHICH ARE THE EXECUTIVE DIRECTOR, THE DIRECTOR OF DEVELOPMENT (TERMINATED MAY 2023), AND THE DIRECTOR OF MARKETING. THE BOARD MEETS ANNUALLY TO DISCUSS THE SALARY OF THE EXECUTIVE DIRECTOR. FORM 990, PART VI, SECTION C, LINE 19 ALL PUBLIC DOCUMENTS ARE MADE AVAILABLE UPON REQUEST AT THE FOUNDATION'S ADDRESS OF OPERATIONS, AS WELL AS ON THEIR WEBSITE. FORM 990, PART IX, LINE 11G OTHER FEES: PROGRAM SERVICE EXPENSES 49,333. MANAGEMENT AND GENERAL EXPENSES 9,844. FUNDRAISING EXPENSES 20,433. TOTAL EXPENSES 79,610. ACCOUNTING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 36,154. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 36,154.